Free Trial
NASDAQ:CLOV

Clover Health Investments (CLOV) Stock Price, News & Analysis

$2.51
-0.15 (-5.64%)
(As of 09/6/2024 ET)
Today's Range
$2.46
$2.68
50-Day Range
$1.20
$3.50
52-Week Range
$0.61
$3.82
Volume
6.81 million shs
Average Volume
8.09 million shs
Market Capitalization
$1.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Clover Health Investments MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
5.91% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.54mentions of Clover Health Investments in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.13) to ($0.12) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.44 out of 5 stars

Medical Sector

868th out of 910 stocks

Hospital & Medical Service Plans Industry

11th out of 11 stocks

CLOV stock logo

About Clover Health Investments Stock (NASDAQ:CLOV)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

CLOV Stock Price History

CLOV Stock News Headlines

Clover Health Investments (NASDAQ:CLOV) Shares Gap Up to $2.50
Biden’s Capital Gains Tax to Devastate Savings!
Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.
Clover Health Jumps 21% After Unit's Deal With The Iowa Clinic
Biden’s Capital Gains Tax to Devastate Savings!
Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.
Clover Health Investments, Corp. (7QD.F)
CLOV Aug 2024 3.000 put (CLOV240816P00003000)
See More Headlines
Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/05/2024
Today
9/07/2024
Next Earnings (Estimated)
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Insurance
Current Symbol
NASDAQ:CLOV
Fax
N/A
Employees
680
Year Founded
N/A

Profitability

Net Income
$-213,360,000.00
Pretax Margin
-7.12%

Debt

Sales & Book Value

Annual Sales
$2.09 billion
Book Value
$0.65 per share

Miscellaneous

Free Float
385,831,000
Market Cap
$1.25 billion
Optionable
Optionable
Beta
2.13
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Vivek GaripalliMr. Vivek Garipalli (Age 45)
    Co-Founder & Executive Chairman
  • Mr. Andrew Toy (Age 45)
    Co-Founder, CEO & Director
    Comp: $1.01M
  • Mr. Brady Priest J.D. (Age 47)
    Chief Executive Officer of Home Care
    Comp: $587.36k
  • Mr. Terrence Ronan (Age 64)
    Interim CFO, Principal Financial Officer & Principal Accounting Officer
  • Mr. Conrad Wai (Age 43)
    Chief Technology Officer
  • Mr. Derrick L. Nueman
    Head of Investor Relations & Corporate strategy
  • Ms. Wendy Richey
    Chief Compliance Officer
  • Ms. Karen Soares
    General Counsel, Senior VP & Corporate Secretary
  • Ms. Rachel Fish
    Chief People Officer
  • Ms. Jamie L. Reynoso (Age 54)
    Chief Executive Officer of Medicare Advantage
    Comp: $461.74k

CLOV Stock Analysis - Frequently Asked Questions

How have CLOV shares performed this year?

Clover Health Investments' stock was trading at $0.9521 at the beginning of 2024. Since then, CLOV stock has increased by 163.6% and is now trading at $2.51.
View the best growth stocks for 2024 here
.

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) announced its quarterly earnings results on Monday, August, 5th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. The business had revenue of $356.26 million for the quarter, compared to analysts' expectations of $338.70 million. Clover Health Investments had a negative trailing twelve-month return on equity of 36.55% and a negative net margin of 7.30%.

Who are Clover Health Investments' major shareholders?

Top institutional shareholders of Clover Health Investments include Renaissance Technologies LLC (2.27%), XTX Topco Ltd (0.15%), Susquehanna International Group LLP and AQR Capital Management LLC (0.15%). Insiders that own company stock include Anna U Loengard, Chelsea Clinton and Chamath Palihapitiya.
View institutional ownership trends
.

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLOV) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners